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Health effects of vitamin and mineral 
supplements
Growing numbers of healthy people are taking dietary supplements but there is little evidence that 
they protect against non-communicable diseases, say Fang Fang Zhang and colleagues
Vitamin and mineral supple-ments are the most commonly used dietary supplements by populations worldwide.1-4 The amount of micronutrients 
they provide ranges from less than rec-
ommended intakes to much more, mak-
ing them important contributors to total 
intakes. While supplements can be used to 
correct micronutrient deficiency or main-
tain an adequate intake, over-the-counter 
supplements are most often taken by peo-
ple with no clinical signs or symptoms of 
deficiency. However, the effect of vitamin 
and mineral supplements on the risk of 
non-communicable diseases in “gener-
ally healthy” populations is controversial. 
We examine patterns of supplement use 
and the evidence on their effects from ran-
domised trials.
Who uses supplements?
Vitamin and mineral supplements have a 
large worldwide market, but we will focus 
on their use in North America and Europe, 
where there is most evidence on patterns of 
use and health outcomes. The use of vita-
min, mineral, and fish oil supplements5 is 
common among adults in North America 
(fig 1).6 The prevalence of use has increased 
for some individual nutrients—for example, 
there was a fourfold increase in use of vita-
min D supplements among US adults from 
1999 to 2012, excluding intake obtained 
from multivitamin and mineral.7 The use 
of omega-3 fatty acid supplements also 
increased sevenfold.7
Supplement use is generally less 
prevalent in other countries than in the US 
and Canada but varies widely (eg, Denmark 
51%, South Korea 34%, Australia 43%, UK 
36%, Spain 6%, Greece 2%).2-4 Different 
methods for assessing supplement use 
may contribute to the different prevalence 
in high income countries. National survey 
data for supplement use in the general 
population remain scarce for low and 
middle income countries.
Supplement use varies considerably 
among population subgroups within 
North America and Europe. In the US, 
>70% of adults aged ≥65 years use 
supplements8 compared with a third of 
children and adolescents.9 More women 
than men use supplements.6 Supplement 
use correlates positively with educational 
and socioeconomic status.10 It also clusters 
with healthy lifestyle factors such as not 
being a smoker or heavy drinker, not being 
overweight or obese, and being physically 
active.6 Importantly, people who use 
supplements tend to have a better overall 
diet quality than those who don’t use them 
and their nutrient intake from foods mostly 
meets recommended intake levels.11 12
Are supplements needed?
Use of supplements contributes substan-
tially to total vitamin and mineral intakes at 
the population level.13 Intake of vitamin B6, 
thiamin, and riboflavin among US adults is 
at least five times higher from supplements 
than from foods, and intakes are 15 to 20 
times higher for supplements for vitamins 
B12 and E.6 Consequently, supplement use 
considerably reduces the proportion of the 
general population with inadequate nutri-
ent intake (box 1).
This is especially true for vitamins and 
minerals identified as “shortfall” nutrients 
such as calcium and vitamin D (fig 2).14 
Despite the high use of supplements, 
inadequate intakes of micronutrients are 
still common in high income countries, 
where dietary patterns are typically energy 
rich but nutrient poor. 
In low and middle income countries, 
where specific micronutrient deficiencies 
are prevalent (eg, of iodine, iron, zinc, 
and vitamin A), supplementation is 
recommended when food based approa-
ches such as dietary modification, fortifi-
cation, or food provision are unable to 
achieve inadequate intake.15 In the US 
and other countries, food fortification and 
enrichment such as the addition of iodine 
to salt, vitamin D to milk, and B1 and B3 
vitamins to refined flour have contributed to 
the virtual elimination of their syndromes 
of deficiency (goitre, rickets, beriberi, and 
pellagra, respectively).16 17
The widespread use of vitamin and 
mine ral supplements in high income 
countries seems to contribute to an 
increase in population prevalence of 
intake above the upper tolerable level 
(box 1).6 Although the overall proportion 
of US adults with intakes above the upper 
level is below 5% for most nutrients (fig 
2), some population subgroups may have 
high rates of excess intake. For example, 
in a Canadian national survey, over 80% of 
children aged 1-3 years who took dietary 
supplements consumed vitamin A and 
niacin at levels above the upper limit.18 
In the US, excessive intake was noted for 
vitamin A (97%) and zinc (68%) among 
toddlers who were given supplements.19 
High quality evidence is lacking on the 
long term adverse effects of excess intake 
for several nutrients so it is unclear 
whether this is a cause for concern.
Do supplements protect against non-
communicable diseases?
It remains controversial whether supple-
ments are effective in reducing the risk of 
non-communicable diseases. In contrast to 
results of observational studies, the accu-
mulated evidence from randomised con-
trolled trials does not support benefits of 
Key Messages
•   Randomised trial evidence does not 
support use of vitamin, mineral, and 
fish oil supplements to reduce the risk 
of non-communicable diseases
•   People using supplements tend to be 
older, female, and have higher educa-
tion, income, and healthier lifestyles 
than people who do not use them
•   Use of supplements appreciably 
reduces the prevalence of inadequate 
intake for most nutrients but also 
increases the prevalence of excess 
intake for some nutrients 
•   Further research is needed to assess 
the long term effects of supplements 
on the health of the general popula-
tion and in individuals with specific 
nutritional needs, including those 
from low and middle income countries
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supplements in reducing risks of cardiovas-
cular disease, cancer, or type 2 diabetes in 
healthy people with no clinical nutritional 
deficiencies.
Cardiovascular disease
An updated systematic review of 15 ran-
domised trials published after the 2013 
US Preventive Service Task Force (USPSTF) 
review20 confirmed the lack of benefits of 
supplements on cardiovascular events, 
mostly among patients with risk factors.21 
Although randomised trials of folic acid, 
alone or in combination with vitamins 
B12 or B6, found significant reductions in 
plasma homocysteine levels, total cardio-
vascular events were not reduced. Another 
systematic review reported a reduced risk 
of stroke in association with supplementa-
tion of homocysteine lowering B vitamins,22 
but the result was largely driven by one 
large trial in China.23 Overall, there is no 
consistent evidence to support the use of 
antioxidant supplements for reducing car-
diovascular risk.22 24
The Vitamin D and Omega-3 Trial 
(VITAL), one of the few randomised trials 
of supplements for primary prevention of 
cardiovascular disease, found no effect 
of vitamin D supplementation (2000 IU/
day) on its primary endpoint (myocardial 
infarction, stroke, or cardiovascular death) 
in healthy people.25 Previous large scale 
trials such as the Women’s Health Initiative 
Calcium and Vitamin D Supplementation 
Study26 and the Vitamin D Assessment 
Study27 also showed vitamin D supplements, 
alone or in combination with calcium, had 
no effect on cardiovascular risk.
Supplementation with omega-3 fatty 
acids (1 g/day) did not reduce the risk 
of major cardiovascular events among 
healthy people in the VITAL trial.28 
However, benefits were found for some 
secondary endpoints such as total 
myocardial infarctions. This result is 
largely consistent with findings from meta-
analyses that fish oil supplementation 
did not have substantial effects on the 
primary or secondary prevention of 
cardiovascular disease.29 30 However, a 
meta-analysis including the most recent 
trials reported a significant reduction in 
risk of myocardial infarction.31 Further 
studies are needed to determine whether 
fish oil supplementation has a greater 
effect on risk of heart disease than of 
stroke.32
Cancer
Current evidence does not support a role 
of vitamin and mineral supplements in 
reducing cancer risk, with some evidence 
suggesting potential harm. β-Carotene 
supplementation increased the risk of 
lung cancer among high risk individuals in 
two randomised trials. The α-Tocopherol, 
β-Carotene Cancer Prevention Study 
reported an 18% increase in relative risk 
among smokers randomised to β-carotene 
(20 mg/day) compared with those who did 
not.33 The β-Carotene and Retinol Efficacy 
Trial found that β-carotene (30 mg/day) 
plus vitamin A as retinol (25 000 IU/day) 
increased risk by 28% among smokers 
and workers with occupational exposure 
to asbestos.34 The Selenium and Vitamin 
E Cancer Prevention Trial found that vita-
min E (400 IU/day) supplementation was 
associated with a 17% increase in prostate 
cancer risk among men.35
Although maternal folic acid supplemen-
tation has been proved to reduce the risk 
of neural tube defects, concerns have been 
raised that high folic acid exposure may 
promote cancer progression, especially in 
countries with mandatory fortification.36 
Most notably, folic acid supplementation 
at ≥1 mg/day may promote the growth 
of undiagnosed colorectal adenomas.37 
However, a meta-analysis of 11 rando-
mised trials concluded that folic acid 
supplementation neither increased nor 
decreased site specific cancer risk within 
the first five years of supplementation.38
Randomised trials have failed to detect 
a benefit of vitamin D supplementation, 
alone or combined with calcium, on cancer 
risk at either high or low doses25 39 despite 
some evidence suggesting reduced total 
cancer mortality.25 40 The limited evidence 
on fish oil supplementation suggests it does 
not reduce cancer risk.28 41
Type 2 diabetes
Current evidence does not support the 
use of supplements with vitamins C or E, 
β-carotene, or fish oil to reduce the risk of 
type 2 diabetes, although the overall evi-
dence from randomised trials is limited.42 43 
A recent placebo controlled trial of vitamin 
D supplementation (4000 IU/day) failed to 
reduce the risk of type 2 diabetes despite 
significantly increasing serum 25-hydroxy-
vitamin D concentrations.44
Osteoporosis
Recent evidence regarding the effects of 
vitamin D and calcium supplementation 
is inconsistent. A meta-analysis of trials in 
community living older adults found that 
Box 1: Population nutrient intake—definitions
•	Estimated	average	requirement is the daily level of nutrient intake estimated to meet the 
requirement of half of healthy people in a population 
•	Inadequate	nutrient	intake—The population prevalence of inadequate intake is estimated 
as the percentage of the population with nutrient intake below the estimated average 
requirement
•	Tolerable	upper	intake is the highest daily nutrient intake that is likely to pose no risk of 
adverse health effects to almost all healthy people in a population. As intake increases 
above the upper level, the potential risk of adverse effects increases. 
•	Excess	intake—The population prevalence of excess intake is estimated as the percentage of 
the population with nutrient intake above the upper level
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Fig 1 | Proportion of US adults taking commonly vitamin, mineral, and fish oil supplements, 
National Health and Nutrition Examination Survey 1999-20146
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vitamin D or calcium supplementation did 
not reduce the risk of hip fracture or total 
fracture,45 whereas another meta-analysis 
reported that while vitamin D alone did not 
reduce fracture risk, combined calcium and 
vitamin D supplementation decreased the 
relative risk of hip fracture (16%) and all 
fractures (6%) among older adults.46 Ongo-
ing research is assessing the effect of high 
dose vitamin D supplements on several 
health outcomes, including fractures,46 
but a recent three year trial of 400, 4000, 
or 10 000 IU/day reported that the higher 
doses reduced volumetric bone density, 
suggesting potential for harm.47 In the 
absence of clear evidence on supplemen-
tation, it is prudent to ensure that dietary 
recommendations on calcium and vitamin 
D intakes are met through food and sup-
plementation.
What next?
To date, randomised trials have largely 
shown no benefit of vitamin, mineral, and 
fish oil supplements on the risk of major 
non-communicable diseases in people 
without clinical nutritional deficiency. 
These results contrast with findings from 
observational studies, where supplemental 
nutrient intakes are often associated with a 
reduced risk of these diseases. The appar-
ent associations from observational studies 
may result from unknown or unmeasured 
confounding factors such as socioeconomic 
status and lifestyle factors, including a bet-
ter overall diet. 
Although randomisation reduces 
confounding, relying exclusively on the 
results of randomised trials also has 
limitations. Trials are often conducted 
among high risk populations with pre-
existing conditions, so the findings may 
not be applicable to healthy individuals. 
Supplements may also have health 
benefits for population subgroups, such 
as people with inadequate nutrient intake 
from foods, but randomised trials are not 
usually designed to evaluate subgroup 
differences. Furthermore, financial and 
practical constraints mean that most trials 
are able to investigate only a single dose, 
which may result in selection of a dose that 
is either too low (no efficacy) or too high 
(untoward outcomes).
Nutrients obtained from foods and 
supplements may confer different health 
effects. The Cancer Prevention Study 
(CPS)-II Nutrition Cohort found that 
supplemental calcium intake at ≥1000 mg/
day was associated with an increased risk 
of all-cause mortality in men whereas high 
levels of calcium intake from foods had no 
harm.48 Among US adults in the National 
Health and Nutrition Examination Survey, 
adequate intake of nutrients from foods, 
but not supplements, was associated 
with a lower risk of all-cause mortality.6 
The benefits of nutrient intake from foods 
may reflect synergistic interactions among 
multiple nutrients and other bioactive 
substances in foods.
The effect of supplements in specific 
populations warrants further investigation. 
Older adults are at an increased risk of 
malnutrition because of reduced nutrient 
intake and age related decreases in the 
bioavailability of some micronutrients. 
Vitamin D supplementation is recommen-
ded for breastfed infants before the 
introduction of whole milk and solid 
foods. Supplements may be more effective 
in reducing the risk of non-communicable 
disease in specific ethnic groups or people 
with low micronutrient intake from foods.28 
With a recent increase in the proportion of 
people reporting that they follow restricted 
dietary patterns such as ketogenic, 
Palaeolithic, vegan, and vegetarian 
diets, the value of supplements to meet 
the needs of these specific populations 
requires evaluation. In addition, potential 
nutrient-gene interactions have rarely 
been examined in studies of dietary 
supplements. Future studies on the role 
of nutrigenetics should help refine and 
personalise targeted recommendations for 
supplement use (box 2).
It is also important to recognise that the 
need for nutrient supplements is different 
in countries where nutrition deficiency 
is common. Ensuring adequate nutrition 
through food fortification and nutrient 
supplementation can be crucial to prevent 
serious adverse outcomes of nutrient 
deficiencies in low and middle income 
countries, especially among children <5 
years, for whom malnutrition contributes 
to more than half their deaths.15
In summary, current evidence does 
not support recommending vitamin or 
fish oil supplements to reduce the risk 
of non-communicable diseases among 
populations without clinical nutritional 
deficiency. Continuing efforts are warranted 
to further understand the potentially 
different roles of nutrients from foods 
versus supplements in health promotion 
among a generally healthy population as 
well as individuals or groups with specific 
nutritional needs, including those living in 
low and middle income countries. These 
efforts, coupled with the integration of new 
research approaches, will better inform 
clinical practice and public health policies.
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Box 2: Areas for research in vitamin and mineral supplementation
•	Differing health effects of nutrients obtained from foods versus supplements
•	Synergistic interactions among multiple nutrients and with other bioactive substances
•	Subpopulation studies (eg, elderly people, ethnic groups, vegans)
•	Nutrigenetics and “omics” sciences
•	Personalised supplementation
•	Specific needs in low and middle income countries
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Fig 2 | Prevalence of inadequate and excess nutrient intake among US Adults, National Health 
and Nutrition Examination Survey 1999-20146
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